You are here:

lidocaine 5% medicated plaster (Versatis)

Advice

Following a resubmission

lidocaine 5% medicated plaster (Versatis®) is accepted for restricted use within NHS Scotland for the treatment of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia).

There are only limited comparative data available for lidocaine plasters, the comparative clinical effectiveness remains unclear. It is restricted to use in patients who are intolerant of first-line systemic therapies for post-herpetic neuralgia or where these therapies have been ineffective.

Drug Details

Drug Name: lidocaine 5% medicated plaster (Versatis)
SMC Drug ID: 334/06
Manufacturer: Grünenthal Ltd
Indication: Treatment of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PHN)
BNF Category:
Sub Category: 15.2 Local anaesthesia
Submission Type: Resubmission
Status: Restricted
Date Advice Published: 11 August 2008

Archived Advice

Full submission 12 March 2007

Back